I'm short a straddle. Sold the FEB $10 puts and the $25 calls. Should be a fun rollercoaster over next few months. I took in about $3.7 premium. So my break even range is $6.3 to $28.7 at expiration.
Better hope they can't come out with that vaccine. This is one case where good news will be a lot more detrimental than bad news. I played the Dec options a little bit back because I didn't want to be short options into an announcement like that.
I agree. The anthrax vaccine contract will provide some support. Even a modestly successful AIDS vaccine announcement would send the stock through the roof, at least for a couple of days.